Duloxetine, 60 mg once daily, for major depressive disorder: a randomized double-blind placebo-controlled trial
MJ Detke, Y Lu, DJ Goldstein, JR Hayes… - Journal of Clinical …, 2002 - psychiatrist.com
Background: Despite treatment advances, major depressive disorder (MDD) is still a
significant cause of morbidity and mortality. Current therapies frequently fall short of …
significant cause of morbidity and mortality. Current therapies frequently fall short of …
Duloxetine, 60 mg Once Daily, for Major Depressive Disorder: A Randomized Double-Blind Placebo-Controlled Trial
MJ Detke, Y Lu, DJ Goldstein, JR Hayes… - J Clin …, 2002 - psychiatrist.com
Background: Despite treatment advances, major depressive disorder (MDD) is still a
significant cause of morbidity and mortality. Current therapies frequently fall short of …
significant cause of morbidity and mortality. Current therapies frequently fall short of …
[引用][C] Duloxetine, 60 mg Once Daily, for Major Depressive Disorder
MJ Detke, Y Lu, DJ Goldstein, JR Hayes… - The Journal of Clinical …, 2002 - cir.nii.ac.jp
Duloxetine, 60 mg Once Daily, for Major Depressive Disorder | CiNii Research CiNii 国立情報学
研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データをさがす 大学 …
研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データをさがす 大学 …
[引用][C] Duloxetine, 60 mg once daily, for major depressive disorder: A randomized double-blind placebo-controlled trial
MJ DETKE, Y LU, DJ GOLDSTEIN… - The Journal of …, 2002 - pascal-francis.inist.fr
Duloxetine, 60 mg once daily, for major depressive disorder: A randomized double-blind
placebo-controlled trial CNRS Inist Pascal-Francis CNRS Pascal and Francis Bibliographic …
placebo-controlled trial CNRS Inist Pascal-Francis CNRS Pascal and Francis Bibliographic …
Duloxetine, 60 mg once daily, for major depressive disorder: a randomized double-blind placebo-controlled trial
MJ Detke, Y Lu, DJ Goldstein… - The Journal of …, 2002 - pubmed.ncbi.nlm.nih.gov
Background Despite treatment advances, major depressive disorder (MDD) is still a
significant cause of morbidity and mortality. Current therapies frequently fall short of …
significant cause of morbidity and mortality. Current therapies frequently fall short of …
Duloxetine, 60 mg once daily, for major depressive disorder: a randomized double-blind placebo-controlled trial.
MJ Detke, Y Lu, DJ Goldstein, JR Hayes… - The Journal of …, 2002 - europepmc.org
Background Despite treatment advances, major depressive disorder (MDD) is still a
significant cause of morbidity and mortality. Current therapies frequently fall short of …
significant cause of morbidity and mortality. Current therapies frequently fall short of …